Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
Want to see ACRS full AI Analyst Report?
Aclaris Therapeutics (ACRS) Ownership Overview
12.34% Insiders
6.93% Mutual Funds
48.81% Other Institutional Investors
10.74% ETFs
21.17% Public Companies and
Individual Investors
The ownership structure of Aclaris Therapeutics (ACRS) stock is a mix of institutional, retail, and individual investors. Approximately 66.48% of the company’s stock is owned by Institutional Investors, 12.34% is owned by Insiders, and 21.17% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 27, 2026 | xxxxxxxxxxxxx | $1359000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $25515270 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $5571086 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $123776 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,950,000 | Insider | 9.99% | 63,054,000 | |
| 6,804,072 | Institution | 4.87% | 30,754,405 | |
| 5,918,605 | Institution | 4.24% | 26,752,095 | |
| 4,396,663 | Institution | 3.15% | 19,872,917 | |
| 4,269,963 | Institution | 3.06% | 19,300,233 | |
| 3,771,568 | Institution | 2.70% | 17,047,487 | |
| 1,543,886 | Insider | 1.11% | 6,978,365 | |
| 1,485,623 | Institution | 1.06% | 6,715,016 | |
| 1,029,478 | Institution | 0.74% | 4,653,241 | |
| 1,014,342 | Institution | 0.73% | 4,584,826 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,269,963 | Institution | 3.06% | 19,300,233 | |
| 1,029,478 | Institution | 0.74% | 4,653,241 | |
| 1,014,342 | Institution | 0.73% | 4,584,826 | |
| 592,568 | Institution | 0.42% | 2,678,407 | |
| 529,599 | Institution | 0.38% | 2,393,787 | |
| 380,978 | Institution | 0.27% | 1,722,021 | |
| 321,579 | Institution | 0.23% | 1,453,537 | |
| 317,019 | Institution | 0.23% | 1,432,926 | |
| 284,604 | Institution | 0.20% | 1,286,410 | |
| 218,018 | Institution | 0.16% | 985,441 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,969,645 | Institution | 2.84% | 14,886,169 | |
| 2,158,828 | Institution | 1.55% | 10,535,081 | |
| 1,097,320 | Institution | 0.79% | 4,114,950 | |
| 923,313 | Institution | 0.66% | 4,570,399 | |
| 923,313 | Institution | 0.66% | 4,570,399 | |
| 923,313 | Institution | 0.66% | 4,570,399 | |
| 798,688 | Institution | 0.57% | 3,897,597 | |
| 763,951 | Institution | 0.55% | 3,728,081 | |
| 450,378 | Institution | 0.32% | 1,688,918 | |
| 325,193 | Institution | 0.23% | 1,609,705 |
FAQ
Who Owns Aclaris Therapeutics (ACRS)?
According to the latest TipRanks data, approximately 48.81% of the company's stock is held by institutional investors, 12.34% is held by insiders, and 21.17% is held by retail investors.
What percentage of Aclaris Therapeutics (ACRS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.81% of Aclaris Therapeutics (ACRS) stock is held by institutional investors.
What percentage of Aclaris Therapeutics (ACRS) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.17% of Aclaris Therapeutics (ACRS) stock is held by retail investors.
Who owns the most shares of Aclaris Therapeutics (ACRS)?
Braden Michael Leonard owns the most shares of Aclaris Therapeutics (ACRS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.